In Reply We posited that the difference between the number of sex-specific statements made in the Drug Trials Snapshots vs the drug label may be owing to the legal requirements imposed on the prescribing information, for which sex demographic labeling is not a required subsection.1 Our premise was that the prescription drug label and Drug Trials Snapshots fulfill different purposes, which may lead to differences in the number of sex-specific statements.
Whyte J, Woodcock J, Wang J. Drug Trials Snapshots and Sexless Drug Labels—Reply. JAMA Intern Med. 2017;177(12):1868–1869. doi:https://doi.org/10.1001/jamainternmed.2017.5646
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: